Mizuho Maintains Buy on Syneos Health, Lowers Price Target to $87
Mizuho analyst Ann Hynes maintains Syneos Health (NASDAQ:SYNH) with a Buy and lowers the price target from $94 to $87.
Syneos Health Stock Tanks After Q2 Sales Miss, FY22 Outlook Cut Citing Macro Economic Trends
Syneos Health Inc’s (NASDAQ:SYNH) Q2 revenue increased 6.1% on a reported basis and 8.3% on a constant currency (CC)…
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Avis Budget, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
FAT Brands Inc. (NASDAQ: FATBB) fell 30% to $10.50. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share.
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Guggenheim Initiates Coverage On Syneos Health with Buy Rating, Announces Price Target of $81
Guggenheim analyst Sandy Draper initiates coverage on Syneos Health (NASDAQ:SYNH) with a Buy rating and announces Price Target of $81.
Syneos Health Shares Jump On Better Than Expected Q1 Earnings, FY22 Outlook
Syneos Health Inc’s (NASDAQ:SYNH) Q1 revenue increased 10.5% on a reported basis and 11.7% on a constant currency (CC) basis to…